If a drug is a significant substrate for P-glycoprotein, what is the expected effect on its systemic exposure?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Pharmaceutics Xenobiotics Across Bio Membrane Test. Prepare with flashcards and multiple-choice questions, each providing hints and explanations. Get ready for your pharmacy exam!

Multiple Choice

If a drug is a significant substrate for P-glycoprotein, what is the expected effect on its systemic exposure?

Explanation:
P-glycoprotein acts as an intestinal efflux transporter, pumping drugs back into the gut lumen as they are absorbed. When a drug is a significant substrate, a large portion is effluxed before it can reach the bloodstream, reducing the amount that enters systemic circulation. This lowers overall systemic exposure, typically seen as a reduced AUC and often a lower peak concentration. Practically, this is why P-gp substrates can have limited oral bioavailability, and why inhibitors of P-gp can increase exposure.

P-glycoprotein acts as an intestinal efflux transporter, pumping drugs back into the gut lumen as they are absorbed. When a drug is a significant substrate, a large portion is effluxed before it can reach the bloodstream, reducing the amount that enters systemic circulation. This lowers overall systemic exposure, typically seen as a reduced AUC and often a lower peak concentration. Practically, this is why P-gp substrates can have limited oral bioavailability, and why inhibitors of P-gp can increase exposure.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy